A Prospective Investigation of the VWF-ADAMTS 13 Axis in Acute Ischaemic Brain Injury (TIAs and Stroke).

Not yet recruiting

Phase 1 Results N/A

Summary of Purpose

In patients presenting with acute stroke or transient ischaemic attacks (TIA), von Willebrand factor related parameters, including VWF antigen, activity, FVIII:c and propeptides, ADAMTS13 levels and VWF multimers in cases where ADAMTS 13 was reduced will be measured. Global haemostasis will be assessed using thrombin generation and the relation between increase thrombin generation and VWF explored. Thrombin...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 August 2014.

1 Dec 2014 15 Aug 2014 1 Dec 2016 Unavailable 1 Aug 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Conditions

Sponsors

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Contacts